TMOPrepared as a May 26, 2026 registry refresh from the S&P 500 ranks 51-75 market-cap cohort; market metrics are point-in-time estimates and should be reviewed before financial publication.

Thermo Fisher Scientific

Thermo Fisher Scientific supplies analytical instruments, laboratory equipment, reagents, consumables, software, and services for science and health care customers.

CompaniesMarketCap Product analyses

Metadata

Where this company sits

Ticker: TMO
Rank snapshot: ≈ 60
Sector: Health Care
Industry: Life Sciences Tools & Services
Region: United States
Index: S&P 500 · Top 75 by market cap

Metrics

Scoring view

Every metric is paired with a short rationale. The numbers are deliberate, not divine.

Moat

82.0/10

Thermo Fisher has a large installed base, broad catalog, regulated customer relationships, service infrastructure, and a combined instruments-consumables-services model, but some lab equipment and automation workflows are vulnerable to open or lower-cost substitutes.

Decentralizability

34.0/10

High-end analytical instruments, validated diagnostics, and regulated consumables remain difficult to decentralize, while protocol software, lower-end lab automation, and some genetic-analysis tools have credible open-source or community alternatives.

Profitability

76.0/10

Thermo Fisher remained strongly profitable at 2025 scale, with third-party financial summaries reporting about $44.6 billion of revenue and about $6.7 billion of net income.

Price / Earnings

21.7x

Macrotrends reported Thermo Fisher Scientific's P/E ratio at 21.69 as of May 6, 2026; this is market-sensitive and should be treated as a point-in-time estimate.

Market cap

$167.0B

StockAnalysis reported Thermo Fisher's market capitalization at about $167 billion as of May 21, 2026, broadly consistent with other late-May 2026 market-data snapshots.

Freed-up capital potential

$0.0

Derived from market cap, moat resistance, decentralizability, and profitability. It is a directional estimate of value capture that could come under pressure if open alternatives compound.

Narrative

Why the company matters

A short editorial overview plus the current thesis on moat strength and decentralization pressure.

Business mix

Thermo Fisher Scientific is a scaled life-sciences infrastructure supplier spanning analytical instruments, life-sciences reagents, specialty diagnostics, laboratory products, biopharma services, and clinical research services.

Its brands include Thermo Scientific for instruments, equipment, software, services, and consumables, and Applied Biosystems for genetic-analysis systems such as PCR and sequencing-adjacent instruments.

Market position

The company benefits from broad catalog depth, regulated customer workflows, global distribution, installed instrument bases, service contracts, and procurement relationships with research, clinical, pharmaceutical, biotechnology, academic, industrial, and government customers.

Thermo Fisher reported roughly $44.6 billion of 2025 revenue, and market-data sources placed its market capitalization near $167 billion in late May 2026.

Moat reading

Thermo Fisher's moat is strongest where customers need validated workflows, repeatable consumables, service coverage, regulatory documentation, and purchasing simplicity across many lab categories. Its scale lets it bundle instruments, reagents, consumables, support, and channel access in a way smaller vendors struggle to match.

The moat is less absolute in commodity lab equipment, software-adjacent workflows, and lower-complexity automation where open-source protocols, lower-cost robotics, shared designs, refurbished equipment, and community methods can pressure closed vendor ecosystems.

Decentralization reading

Thermo Fisher is structurally centralized because it manufactures or channels specialized instruments, branded consumables, validated reagents, and support-heavy systems through a global corporate platform.

The decentralization opening is not a full replacement of high-end analytical instrumentation. It is more credible around open lab automation, shared protocol execution, low-cost genetic-analysis hardware, open instrument-control layers, and federated lab networks that reduce dependence on proprietary software and single-vendor consumables.

Products

Where the moat actually touches users

These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 3 structured disruption concepts across the current product set.

3 disruption concepts tracked0 documented exceptions

Thermo Scientific

Analytical instruments, laboratory equipment, software, services, and consumables

2 concepts

Thermo Scientific is Thermo Fisher's flagship instrument and lab-equipment brand, covering areas such as chromatography, mass spectrometry, electron microscopy, sample preparation, cold storage, lab equipment, chemicals, software, services, and consumables.

Open analysis

Applied Biosystems

Genetic analysis instruments and reagents

1 concept

Applied Biosystems is Thermo Fisher's genetic-analysis brand for PCR, real-time PCR, thermal cyclers, capillary electrophoresis, and related molecular-biology workflows.

Open analysis

Technology waves

Strategic lenses

These are the repo's explicit bias terms: the technologies expected to keep making incumbents less inevitable over time.

Microfactories and automated mini-home production

Small, software-defined manufacturing cells could make localized production less eccentric and more default.

• Products with heavy branding but generic bill-of-materials profiles look increasingly vulnerable.
• Logistics moats still matter, but their margin for arrogance should narrow.
• Open-source production recipes can pressure both price and product differentiation.

Printed electronics and PCB tooling

PCB fabrication, chip packaging, and increasingly automated electronics assembly continue shrinking the distance between prototype and local production.

• Incumbents with hardware lock-in should be evaluated against a future of much cheaper custom electronics.
• Pick-and-place automation lowers the coordination cost for distributed manufacturing cells.
• The most durable hardware moats may migrate toward fabs, ecosystems, and compliance rather than assembly itself.

Paper trail